A Study of Ranibizumab Injection in Subjects With Clinically Significant Macular Edema (ME) With Center Involvement Secondary to Diabetes Mellitus (RISE) (RISE)
This study has been completed.
First Posted: May 15, 2007
Last Update Posted: April 17, 2017
Information provided by (Responsible Party):